Dabrafenib Impurity 30 | CAS 437-86-5 - Request Quote
Dabrafenib Impurity 30
| SZ CAT No: | SZ-D120046 |
| CAS No | 437-86-5 |
| Mol.F. | C7H6FNO2 |
| Mol.Wt. | 155.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabrafenib Impurity 30 is chemically 2-Fluoro-1-methyl-3-nitrobenzene. Dabrafenib Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Dabrafenib Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabrafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 437-86-5
Purchase 437-86-5
Order 437-86-5
Enquire 437-86-5
price of 437-86-5
437-86-5 Supplier
437-86-5 Manufacturer
437-86-5 Exporter
buy high quality Dabrafenib Impurity 30
Purchase Dabrafenib Impurity 30
Dabrafenib Impurity 30 suppliers
Dabrafenib Impurity 30 manufacturers
Dabrafenib Impurity 30 price
Order Dabrafenib Impurity 30
Enquire Dabrafenib Impurity 30
Dabrafenib Impurity 30 cost
Dabrafenib Impurity 30 Supplier
Dabrafenib Impurity 30 Distributor
Dabrafenib Impurity 30 for Method Validation
Dabrafenib Reference Standard
Dabrafenib Impurity 30 for ANDA Filing
Dabrafenib Impurity 30 for Forced Degradation Studies
Dabrafenib Impurity 30 Identification Standards
Dabrafenib Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


